Press Releases

Jul 29, 2024 7:00am EDT

CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report

Jun 06, 2024 7:00am EDT

CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data

May 29, 2024 7:00am EDT

CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update

May 16, 2024 7:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Apr 04, 2024 7:00am EDT

COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 26, 2024 8:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Feb 15, 2024 8:00am EST

CollPlant Issues Letter to Shareholders

Jan 08, 2024 7:18am EST

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

Jan 02, 2024 7:00am EST

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

Nov 29, 2023 7:00am EST

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023